Cannabis Business Advisors Launches DEA Readiness Platform for Early-Mover Advantage in DEA Registration

PHOENIX, AZ — The Cannabis Business Advisors (CBA) has launched the DEA Readiness Platform, a compliance toolkit built to help state-licensed medical cannabis operators prepare a DEA registration ahead of the statutory June 27, 2026 registration deadline. The platform packages the federal documentation, standard operating procedures, and inventory-separation workflows that a registration filing actually requires — the documents, not just an explanation of the rule. This post is the official on-site record of CBA’s announcement, originally distributed June 19, 2026 via EINPresswire and syndicated to the National Law Review.

The deadline stems from a regulatory change specific to state-licensed medical cannabis. Per the U.S. Department of Justice final order as published in the Federal Register (notice 2026-08177; see also DEA.gov), state-licensed medical marijuana is placed into Schedule III of the Controlled Substances Act, giving operators in that specific category a defined federal on-ramp to register. This change applies only to state-licensed medical marijuana. It is not the broader Schedule I-to-III rescheduling of marijuana generally, which remains unresolved and is set for an administrative hearing opening June 29, 2026. Operators should not read this as marijuana being rescheduled across the board.

“Submitting early is one of the most important steps medical cannabis operators can take right now, but an application is only as strong as the compliance framework behind it,” said Sara Gullickson, founder and CEO of CBA. “Many operators assume their state license means they are already prepared for federal scrutiny, but state-level compliance records are often not reviewed with the same rigor due to limited agency resources. We created this storefront to give operators immediate access to the policies, procedures, and documentation they need to strengthen their readiness and protect the licenses they worked so hard to secure.”

Filings are due by the statutory 60th day, June 27, 2026; because that date falls on a Saturday, June 26 is the practical filing deadline. Operators who file in time may receive a priority review — CBA cites an approximately six-month response target, not a guarantee — and may be able to continue operating during the pendency of their application. None of these outcomes is assured for any specific operator, and timelines and eligibility turn on individual facts.

The platform’s contents map to what reviewers expect to see in a registration file:

• Federal documentation templates for the registration package
• Standard Operating Procedures (SOPs) aligned to federal expectations
• Diversion-prevention protocols
• Dual-market inventory-separation workflows for operators serving both state and federal channels
• Chain-of-custody tracking models
• Enhanced recordkeeping frameworks

There is also a financial dimension operators are watching closely. Schedule III placement is widely expected to remove these operations from the reach of Internal Revenue Code Section 280E, the provision that has long barred cannabis businesses from deducting ordinary operating expenses. Whether — and how — that affects any given operator’s tax position depends on its specific circumstances, and operators should consult their tax advisor before acting.

“Law firms tell you what the rule says. We hand you the documents that get you registered,” said Maxime Kot, President of CBA. “The difference between an operator who is ready on June 26 and one who is scrambling is not knowledge of the law. It’s whether the paperwork already exists, in the right form, signed and filed. That’s the gap this platform closes.”

“This is a defining moment for medical cannabis operators,” Gullickson said. “Those that invest in compliance readiness now are better positioned to preserve license value, protect stakeholder investment, and adapt as the industry moves toward a more federally integrated marketplace.”

Founded in 2020, CBA advises cannabis operators on licensing preparation, operational analysis, M&A support, and exit strategy. The DEA Readiness Platform extends that work into a self-serve, document-first product for operators who need to be filing-ready quickly.

Get the full overview and timeline →

Buy the DEA Readiness Platform on the CBA store →

This is general information, not legal or tax advice. Consult qualified counsel. Primary sources: U.S. Department of Justice final order; Federal Register notice 2026-08177; DEA.gov.

About The Cannabis Business Advisors
The Cannabis Business Advisors (CBA) is a Phoenix-based advisory firm founded in 2020, serving cannabis operators with licensing preparation, operational analysis, M&A support, and exit strategy. Led by founder and CEO Sara Gullickson and President Maxime Kot. The Cannabis Business Advisors, 1709 E Bethany Home Road, Phoenix, AZ 85016. (602) 290-9424. Info@TheCannabisBusinessAdvisors.com.